About Hospital Co. of America (NYSE:HCA)
HCA Healthcare, Inc., through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of February 12, 2018, it owned and operated 179 hospitals and 120 freestanding surgery centers, and various other healthcare facilities in 20 states and the United Kingdom. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Industry, Sector and Symbol
Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNYSE:HCA
CUSIP40412C10
Phone615-344-9551
Debt
Debt-to-Equity Ratio-6.58%
Current Ratio1.62%
Quick Ratio1.36%
Price-To-Earnings
Trailing P/E Ratio14.95
Forward P/E Ratio11.31
P/E Growth0.98
Sales & Book Value
Annual Sales$47.65 billion
Price / Sales0.72
Cash Flow$13.1213 per share
Price / Cash7.50
Book Value($14.11) per share
Price / Book-6.97
Profitability
EPS (Most Recent Fiscal Year)$6.59
Net Income$2.22 billion
Net Margins4.89%
Return on Equity-49.49%
Return on Assets7.21%
Miscellaneous
Employees253,000
Outstanding Shares349,900,000
Hospital Co. of America (NYSE:HCA) Frequently Asked Questions
What is Hospital Co. of America's stock symbol?
Hospital Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCA."
How often does Hospital Co. of America pay dividends? What is the dividend yield for Hospital Co. of America?
Hospital Co. of America declared a quarterly dividend on Wednesday, January 31st. Stockholders of record on Thursday, March 1st will be paid a dividend of $0.35 per share on Friday, March 30th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Wednesday, February 28th. View Hospital Co. of America's Dividend History.
How were Hospital Co. of America's earnings last quarter?
Hospital Co. of America (NYSE:HCA) released its quarterly earnings data on Tuesday, January, 30th. The company reported $2.12 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.87 by $0.25. The company had revenue of $11.56 billion for the quarter, compared to analyst estimates of $11.19 billion. Hospital Co. of America had a net margin of 4.89% and a negative return on equity of 49.49%. The firm's revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.80 EPS. View Hospital Co. of America's Earnings History.
When is Hospital Co. of America's next earnings date?
What guidance has Hospital Co. of America issued on next quarter's earnings?
Hospital Co. of America updated its FY18 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of $8.50-9.00 for the period, compared to the Thomson Reuters consensus estimate of $7.56. The company issued revenue guidance of $45.0-46.0 billion, compared to the consensus revenue estimate of $45.32 billion.
What price target have analysts set for HCA?
23 brokerages have issued 12-month target prices for Hospital Co. of America's shares. Their forecasts range from $81.00 to $122.00. On average, they expect Hospital Co. of America's share price to reach $105.8333 in the next year. View Analyst Ratings for Hospital Co. of America.
What are Wall Street analysts saying about Hospital Co. of America stock?
Here are some recent quotes from research analysts about Hospital Co. of America stock:
- 1. According to Zacks Investment Research, "HCA Healthcare’s continues to suffer from weak commercial business that has faced declining volumes of admissions over the last few quarters. High level of bad debts and disappointing international business are other headwinds. The company is expected to report first quarter results in May first week. An unfavorable Zacks Rank #4 and an Earnings ESP of -2.40% makes earnings surprise prediction difficult. Nonetheless, HCA Healthcare’s shares have outperformed the industry in a year’s time. Its top line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions have helped the company gain a strong foothold in the industry." (4/17/2018)
- 2. Cantor Fitzgerald analysts commented, "HCA reported 4Q17 results that were better than anticipated, although adjusted EPS was impacted by a non-cash increase in the company’s provision for income taxes related to TCJA. Shares are up 5% in early trading." (1/30/2018)
Who are some of Hospital Co. of America's key competitors?
Some companies that are related to Hospital Co. of America include GlaxoSmithKline (GSK), Becton Dickinson (BDX), Stryker (SYK), Anthem (ANTM), Allergan (AGN), Aetna (AET), Biogen (BIIB), Intuitive Surgical (ISRG), Shire (SHPG), Fresenius (FSNUY), Vertex Pharmaceuticals (VRTX), Zoetis (ZTS), Humana (HUM), Beximco Pharmaceuticals (BXP), Express Scripts (ESRX), Boston Scientific (BSX), Takeda Pharmaceutical (TKPYY) and Illumina (ILMN).
Who are Hospital Co. of America's key executives?
Hospital Co. of America's management team includes the folowing people:
- Mr. R. Milton Johnson, Chairman & CEO (Age 61)
- Mr. Samuel N. Hazen, Pres & COO (Age 58)
- Mr. William B. Rutherford, Exec. VP & CFO (Age 54)
- Dr. Jonathan B. Perlin, Pres of Clinical Services & Chief Medical Officer (Age 57)
- Mr. Charles J. Hall, Pres of National Group (Age 65)
Has Hospital Co. of America been receiving favorable news coverage?
Media stories about HCA stock have trended somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Hospital Co. of America earned a media sentiment score of 0.24 on Accern's scale. They also assigned news stories about the company an impact score of 45.65 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of Hospital Co. of America?
Shares of HCA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Hospital Co. of America's stock price today?
One share of HCA stock can currently be purchased for approximately $98.41.
How big of a company is Hospital Co. of America?
Hospital Co. of America has a market capitalization of $34.19 billion and generates $47.65 billion in revenue each year. The company earns $2.22 billion in net income (profit) each year or $6.59 on an earnings per share basis. Hospital Co. of America employs 253,000 workers across the globe.
How can I contact Hospital Co. of America?
Hospital Co. of America's mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company can be reached via phone at 615-344-9551 or via email at [email protected]
MarketBeat Community Rating for Hospital Co. of America (HCA)
MarketBeat's community ratings are surveys of what our community members think about Hospital Co. of America and other stocks. Vote "Outperform" if you believe HCA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Hospital Co. of America (NYSE:HCA) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
23 Wall Street analysts have issued ratings and price targets for Hospital Co. of America in the last 12 months. Their average twelve-month price target is $105.8333, suggesting that the stock has a possible upside of 7.54%. The high price target for HCA is $122.00 and the low price target for HCA is $81.00. There are currently 2 sell ratings, 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.57 | 2.58 | 2.61 | 2.73 |
| Ratings Breakdown: | 2 Sell Rating(s)
6 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
6 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
5 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
6 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $105.8333 | $104.0526 | $87.8333 | $90.9474 |
| Price Target Upside: | 7.54% upside | 6.35% upside | 0.99% upside | 13.98% upside |
Hospital Co. of America (NYSE:HCA) Consensus Price Target History
Hospital Co. of America (NYSE:HCA) Analyst Ratings History
Show:
(Data available from 4/19/2016 forward)
Hospital Co. of America (NYSE:HCA) Dividend Information
Hospital Co. of America pays an annual dividend of $1.40 per share, with a dividend yield of 1.42%. HCA's most recent quarterly dividend payment was Friday, March 30. Hospital Co. of America pays out 21.24% of its earnings out as a dividend.
| Most Recent Dividend: | 3/30/2018 |
| Annual Dividend: | $1.40 |
| Dividend Yield: | 1.42% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | 21.24% (Trailing 12 Months of Earnings)
16.09% (Based on This Year's Estimates)
14.75% (Based on Next Year's Estimates)
|
Hospital Co. of America (NYSE:HCA) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 1/31/2018 | quarterly | $0.35 | 1.38% | 2/28/2018 | 3/1/2018 | 3/30/2018 |
| 12/6/2012 | special | $2.00 | | 12/13/2012 | 12/17/2012 | 12/21/2012 |
(Data available from 1/1/2013 forward)
Hospital Co. of America (NYSE HCA) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.80%
Institutional Ownership Percentage: 73.49%
Hospital Co. of America (NYSE HCA) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/21/2018 | Charles J Hall | Insider | Sell | 49,882 | $101.29 | $5,052,547.78 | 62,048 |  |
| 2/20/2018 | Thomas F Frist Jr | Major Shareholder | Buy | 28,650 | $101.07 | $2,895,655.50 | 389,855 | |
| 2/16/2018 | Jonathan B Perlin | CMO | Sell | 38,480 | $102.05 | $3,926,884.00 | 119,778 | |
| 2/14/2018 | Charles J Hall | Insider | Sell | 119,637 | $100.14 | $11,980,449.18 | 161,181 | |
| 2/9/2018 | Michael S Cuffe | Insider | Sell | 8,335 | $97.26 | $810,662.10 | 26,089 | |
| 2/6/2018 | Sandra L Morgan | SVP | Sell | 3,698 | $96.91 | $358,373.18 | 5,410 | |
| 2/2/2018 | Ravi S. Chari | SVP | Sell | 16,270 | $101.73 | $1,655,147.10 | | |
| 2/1/2018 | Bill B Rutherford | CFO | Sell | 48,462 | $102.42 | $4,963,478.04 | 41,269 | |
| 2/1/2018 | Charles J Hall | Insider | Sell | 35,949 | $103.09 | $3,705,982.41 | 111,237 | |
| 1/31/2018 | Jonathan B Perlin | CMO | Sell | 23,005 | $101.55 | $2,336,157.75 | 76,713 | |
| 1/31/2018 | Samuel N Hazen | COO | Sell | 56,000 | $100.47 | $5,626,320.00 | 136,017 | |
| 1/30/2018 | Joseph A Sowell III | SVP | Sell | 22,025 | $101.86 | $2,243,466.50 | 27,411 | |
| 1/26/2018 | Joseph A Sowell III | SVP | Sell | 58,175 | $95.00 | $5,526,625.00 | 40,536 | |
| 12/15/2017 | Michael S. Cuffe | Insider | Sell | 2,400 | $86.63 | $207,912.00 | | |
| 11/22/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $78.00 | $167,700.00 | 12,476 | |
| 11/16/2017 | Victor L Campbell | SVP | Sell | 8,000 | $75.82 | $606,560.00 | 127,275 | |
| 11/8/2017 | Victor L Campbell | SVP | Sell | 8,000 | $78.00 | $624,000.00 | 127,275 | |
| 10/17/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $78.00 | $167,700.00 | 12,476 | |
| 9/15/2017 | Michael S. Cuffe | Insider | Sell | 2,150 | $79.87 | $171,720.50 | | |
| 8/15/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $79.88 | $171,742.00 | 12,363 | |
| 7/17/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $86.44 | $185,846.00 | 12,363 | |
| 6/22/2017 | Jonathan B. Perlin | Insider | Sell | 71,063 | $86.00 | $6,111,418.00 | | |
| 6/15/2017 | Michael S. Cuffe | Insider | Sell | 2,150 | $84.86 | $182,449.00 | | |
| 5/23/2017 | Jana Joustra Davis | SVP | Sell | 54,689 | $82.35 | $4,503,639.15 | 107,892 | |
| 5/17/2017 | Sandra L Morgan | SVP | Sell | 5,915 | $82.74 | $489,407.10 | 2,420 | |
| 5/15/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $84.52 | $181,718.00 | 12,254 | |
| 5/11/2017 | Jana Joustra Davis | SVP | Sell | 8,302 | $85.02 | $705,836.04 | 36,589 | |
| 5/10/2017 | Jane D Englebright | SVP | Sell | 5,005 | $85.31 | $426,976.55 | 17,351 | |
| 5/5/2017 | Robert A Waterman | SVP | Sell | 246,000 | $83.12 | $20,447,520.00 | 392,252 | |
| 5/5/2017 | Thomas F Frist Jr | Major Shareholder | Buy | 361,205 | $83.06 | $30,001,687.30 | 167,000 | |
| 4/17/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $85.00 | $182,750.00 | 12,254 | |
| 3/27/2017 | Ravi S Chari | SVP | Sell | 31,956 | $90.00 | $2,876,040.00 | 7,754 | |
| 2/7/2017 | John M Steele | SVP | Sell | 31,535 | $82.55 | $2,603,214.25 | 44,308 | |
| 2/3/2017 | Charles J Hall | Insider | Sell | 100,000 | $83.79 | $8,379,000.00 | 76,969 | |
| 2/3/2017 | Jana Joustra Davis | SVP | Sell | 7,903 | $82.49 | $651,918.47 | 65,711 | |
| 2/2/2017 | Charles J Hall | Insider | Sell | 100,000 | $82.38 | $8,238,000.00 | 92,519 | |
| 1/17/2017 | Michael S Cuffe | Insider | Sell | 2,150 | $80.00 | $172,000.00 | 9,736 | |
| 1/9/2017 | Michael S. Cuffe | Insider | Sell | 4,300 | $78.00 | $335,400.00 | | |
| 11/9/2016 | A Bruce Moore Jr | Insider | Sell | 167,967 | $73.65 | $12,370,769.55 | 207,682 | |
| 11/8/2016 | Sandra L Morgan | SVP | Sell | 18,556 | $76.84 | $1,425,843.04 | 7,968 | |
| 11/7/2016 | Christopher F Wyatt | SVP | Sell | 3,152 | $79.00 | $249,008.00 | 7,558 | |
| 10/28/2016 | Michael S. Cuffe | Insider | Sell | 2,150 | $79.41 | $170,731.50 | | |
| 10/28/2016 | P. Martin Paslick | SVP | Sell | 36,004 | $78.79 | $2,836,755.16 | 35,894 | |
| 5/24/2016 | Alan R Yuspeh | SVP | Sell | 15,000 | $77.82 | $1,167,300.00 | 37,228 | |
| 5/24/2016 | Michael S Cuffe | Insider | Sell | 2,575 | $76.20 | $196,215.00 | 9,868 | |
| 5/20/2016 | Joseph N Steakley | SVP | Sell | 16,327 | $77.07 | $1,258,321.89 | 27,496 | |
| 5/10/2016 | Henry R Kravis | Major Shareholder | Sell | 9,360,958 | $80.12 | $749,999,954.96 | | |
| 5/9/2016 | Juan Vallarino | SVP | Sell | 13,501 | $81.27 | $1,097,226.27 | 74,537 | |
| 5/6/2016 | Charles J Hall | Insider | Sell | 100,023 | $80.99 | $8,100,862.77 | 58,067 | |
| 5/6/2016 | Joseph N Steakley | SVP | Sell | 60,004 | $80.82 | $4,849,523.28 | 37,492 | |
| 5/5/2016 | Jana Joustra Davis | SVP | Sell | 11,970 | $80.02 | $957,839.40 | 116,115 | |
| 5/4/2016 | Charles O Holliday Jr | Director | Buy | 4,000 | $79.68 | $318,720.00 | 8,000 | |
| 5/4/2016 | P. Martin Paslick | SVP | Sell | 18,000 | $79.46 | $1,430,280.00 | 44,892 | |
| 4/28/2016 | John M Steele | SVP | Sell | 40,004 | $82.56 | $3,302,730.24 | 28,238 | |
| 4/28/2016 | Jonathan B Perlin | CMO | Sell | 30,000 | $82.00 | $2,460,000.00 | 15,632 | |
| 4/25/2016 | Michael S Cuffe | Insider | Sell | 2,575 | $80.73 | $207,879.75 | 9,868 | |
| 4/18/2016 | John M Steele | SVP | Sell | 19,464 | $81.00 | $1,576,584.00 | 30,198 | |
| 4/14/2016 | John M Steele | SVP | Sell | 3,036 | $81.00 | $245,916.00 | 13,612 | |
| 3/24/2016 | Michael S Cuffe | Insider | Sell | 2,575 | $76.19 | $196,189.25 | 9,868 | |
| 3/23/2016 | John M Steele | SVP | Sell | 22,500 | $78.00 | $1,755,000.00 | 11,219 | |
| 2/24/2016 | Michael S Cuffe | Insider | Sell | 2,575 | $70.00 | $180,250.00 | 8,425 | |
| 2/19/2016 | Jana Joustra Davis | SVP | Sell | 36,159 | $67.17 | $2,428,800.03 | 109,683 | |
| 2/17/2016 | Jane D. Englebright | SVP | Sell | 4,436 | $67.08 | $297,566.88 | 14,021 | |
| 2/1/2016 | David Gwin Anderson | SVP | Sell | 35,013 | $70.52 | $2,469,116.76 | 94,364 | |
| 1/29/2016 | Victor L. Campbell | SVP | Sell | 165,016 | $68.86 | $11,363,001.76 | 128,220 | |
| 1/28/2016 | Michael S. Cuffe | insider | Sell | 5,150 | $70.00 | $360,500.00 | | |
| 12/1/2015 | Michael S. Cuffe | insider | Sell | 2,575 | $70.00 | $180,250.00 | 4,451 | |
| 10/26/2015 | Michael S. Cuffe | insider | Sell | 2,575 | $70.00 | $180,250.00 | 4,451 | |
| 9/24/2015 | Michael S. Cuffe | insider | Sell | 2,575 | $83.42 | $214,806.50 | 4,451 | |
| 8/25/2015 | Juan Vallarino | SVP | Sell | 27,002 | $85.76 | $2,315,691.52 | 61,361 | |
| 8/24/2015 | Michael S. Cuffe | insider | Sell | 2,575 | $82.32 | $211,974.00 | 4,355 | |
| 8/17/2015 | Donald W Stinnett | SVP | Sell | 67,506 | $91.25 | $6,159,922.50 | | |
| 8/14/2015 | Alan R Yuspeh | SVP | Sell | 14,000 | $91.24 | $1,277,360.00 | | |
| 8/13/2015 | Juan Vallarino | SVP | Sell | 11,036 | $90.89 | $1,003,062.04 | | |
| 6/25/2015 | Jonathan B Perlin | CMO | Sell | 32,010 | $87.31 | $2,794,793.10 | | |
| 6/11/2015 | R Milton Johnson | CEO | Sell | 140,642 | $83.89 | $11,798,457.38 | | |
| 5/22/2015 | Donald W Stinnett | SVP | Sell | 22,502 | $82.39 | $1,853,939.78 | | |
| 5/20/2015 | Jana Joustra Davis | SVP | Sell | 3,302 | $82.74 | $273,207.48 | | |
| 5/19/2015 | Jon M Foster | Insider | Sell | 36,000 | $81.00 | $2,916,000.00 | | |
| 5/19/2015 | Jonathan B Perlin | CMO | Sell | 18,000 | $83.00 | $1,494,000.00 | | |
| 5/18/2015 | A Bruce Moore Jr | Insider | Sell | 100,000 | $80.83 | $8,083,000.00 | | |
| 5/18/2015 | David Gwin Anderson | SVP | Sell | 30,000 | $80.67 | $2,420,100.00 | | |
| 5/18/2015 | Jonathan B Perlin | CMO | Sell | 18,000 | $81.00 | $1,458,000.00 | | |
| 5/18/2015 | R Milton Johnson | CEO | Sell | 140,642 | $79.89 | $11,235,889.38 | | |
| 5/7/2015 | Charles J Hall | Insider | Sell | 252,026 | $74.54 | $18,786,018.04 | | |
| 4/15/2015 | Samuel N Hazen | COO | Sell | 180,000 | $80.00 | $14,400,000.00 | | |
| 2/23/2015 | Charles J Hall | Insider | Sell | 50,000 | $70.10 | $3,505,000.00 | | |
| 2/12/2015 | Jane D Englebright | SVP | Sell | 10,774 | $69.06 | $744,052.44 | | |
| 1/12/2015 | Donald W Stinnett | SVP | Sell | 2,521 | $76.00 | $191,596.00 | | |
| 12/23/2014 | John M Steele | SVP | Sell | 14,000 | $75.00 | $1,050,000.00 | | |
| 12/23/2014 | Jonathan B Perlin | CMO | Sell | 10,000 | $75.00 | $750,000.00 | | |
| 12/23/2014 | Samuel N Hazen | Insider | Sell | 180,051 | $75.00 | $13,503,825.00 | | |
| 11/3/2014 | John M Steele | SVP | Sell | 13,000 | $72.00 | $936,000.00 | | |
| 11/3/2014 | Jonathan B Perlin | CMO | Sell | 10,000 | $72.00 | $720,000.00 | | |
| 8/4/2014 | Samuel N Hazen | Insider | Sell | 19,374 | $66.00 | $1,278,684.00 | | |
| 7/30/2014 | David Gwin Anderson | SVP | Sell | 22,524 | $66.53 | $1,498,521.72 | | |
| 7/16/2014 | Juan Vallarino | SVP | Sell | 15,000 | $60.00 | $900,000.00 | | |
| 6/20/2014 | Juan Vallarino | SVP | Sell | 15,000 | $57.50 | $862,500.00 | | |
| 6/5/2014 | Jonathan B Perlin | CMO | Sell | 20,000 | $55.00 | $1,100,000.00 | | |
| 5/6/2014 | Wayne Joseph Riley | Director | Sell | 10,000 | $52.00 | $520,000.00 | 6,749 | |
| 5/5/2014 | David Gwin Anderson | SVP | Sell | 42,007 | $52.22 | $2,193,605.54 | 94,713 | |
| 5/2/2014 | A Bruce Moore, Jr. | Insider | Sell | 75,174 | $52.53 | $3,948,890.22 | 133,892 | |
| 5/1/2014 | Juan Vallarino | SVP | Sell | 15,000 | $52.50 | $787,500.00 | 72,419 | |
| 4/30/2014 | John Rowe | Director | Buy | 14,356 | $52.24 | $749,957.44 | 20,536 | |
| 2/19/2014 | Charles Hall | Insider | Sell | 185,596 | $49.92 | $9,264,952.32 | 11,141 | |
| 2/7/2014 | Samuel Hazen | Insider | Sell | 29,016 | $48.00 | $1,392,768.00 | 28,093 | |
| 11/26/2013 | Juan Vallarino | SVP | Sell | 22,042 | $45.00 | $991,890.00 | 91,744 | |
| 9/18/2013 | Donald Stinnett | SVP | Sell | 12,500 | $42.00 | $525,000.00 | 51,438 | |
| 8/20/2013 | John Steele | SVP | Sell | 33,189 | $38.63 | $1,282,091.07 | 6,645 | |
| 8/14/2013 | Juan Vallarino | SVP | Sell | 50,142 | $39.49 | $1,980,107.58 | 91,744 | |
| 5/17/2013 | Jon M Foster | Insider | Sell | 15,955 | $39.04 | $622,883.20 | | |
| 8/8/2012 | Of America Corp /De/ Bank | Major Shareholder | Sell | 145,491 | $26.91 | $3,915,162.81 | | |
(Data available from 1/1/2013 forward)
Hospital Co. of America (NYSE HCA) News Headlines
| Source: |
|
Hospital Co. of America (NYSE:HCA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Hospital Co. of America (NYSE:HCA) Income Statement, Balance Sheet and Cash Flow Statement
Hospital Co. of America (NYSE HCA) Stock Chart for Thursday, April, 19, 2018
Loading chart…
